Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.00+0.09 (+3.09%)
Close on Nov 17, 2026Market cap $11.85MP/E –Yield –
Onconetix total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Onconetix's total debt was $118.45K at Sep 30, 2024. For fiscal 2023 it was $118.86K, down 74.3% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $118.86K | -74.3% |
| FY2022 | Dec 31, 2022 | $462.52K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $118.45K | -74.4% |
| Q2 FY2024 | Jun 30, 2024 | $111.26K | -75.9% |
| Q1 FY2024 | Mar 31, 2024 | $110.87K | – |
| Q4 FY2023 | Dec 31, 2023 | $118.86K | – |
| Q2 FY2023 | Jun 30, 2023 | $462.52K | – |
| Q4 FY2022 | Dec 31, 2022 | $462.52K | – |
See a number that looks wrong?